跳至主要内容
临床试验/NCT03263988
NCT03263988已完成不适用

A Novel Method of Hemodynamic Monitoring by Piezocapacitative Interlayer Sensor Technology - a Pilot Study

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2017年10月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
1
主要终点
PPV

研究概览

简要总结

Measurement of arterial blood pressure is a basic monitoring in the perioperative setting. It is a standard monitoring to assure an adequate cerebral perfusion pressure and is a basic parameter of hemodynamic optimization. Until now standard methods for blood pressure measurement are non-invasive interval monitoring by arm cuff (Riva-Rocci) or direct, continuous and invasive by inserting an intraarterial catheter. This observational study will show, that a new non-invasive piezocapacitative-interlayer technology will make continuous blood pressure monitoring and non-invasive pulse contour analysis available.

详细描述

Measurement of arterial blood pressure is a basic monitoring in the perioperative setting. It is a standard monitoring to assure an adequate cerebral perfusion pressure and is a basic parameter of hemodynamic optimization. Until now standard methods for blood pressure measurement are non-invasive interval monitoring by arm cuff (Riva-Rocci) or direct, continuous and invasive by inserting an intraarterial catheter. This observational study will show, that a new non-invasive piezocapacitative-interlayer technology will make continuous blood pressure monitoring and non-invasive pulse contour analysis available. For this reason all patients will get a basic monitoring (NIBP, ECG, SpO2)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • elective surgery and general anesthesia
  • age >/= 18 years
  • any surgery in ENT/trauma/gynecology/visceral surgery/thoracic surgery/urology/neuro surgery/cardio surgery (N=10)
  • cardio surgery (N=10)
  • Transcatheter Aortic Valve Implantation (N=20)
  • cystectomy (N=10)
  • neurosurgery with an expected postoperative ICU stay >/= 20 hours (N=10)

排除标准

  • pregnant or breastfeeding patients
  • emergency surgery
  • participation in a clinical interventional study
  • BMI >35 kg/m²
  • impossibility to place the ConCardiac interlayer
  • difference of blood pressure of right and left arm > 12 mmHg
  • pAVK Fontaine IV
  • arrythmia absoluta
  • vitium cordis >/=3
  • ejection fraction <35%
  • TAPSE </=16mm
  • need of IABP

结局指标

主要结局

PPV

时间窗: Duration of surgery and perioperative care (an average of 24 hours)

Percentual error of PPV \< 30% for ConCardiac between ConCardiac and PICCO

次要结局

  • Duration of surgery(Duration of surgery (an average of 4 hours))
  • Length of hospital stay(perioperative (an average of 10 days))
  • Blood products and volume needed perioperative(perioperative (an average of 10 days))
  • Duration of anesthesia(Duration of surgery (an average of 4 hours))
  • Duration of mechanical ventilation(Duration of surgery (an average of 4 hours))
  • Duration of renal replacement therapy(perioperative (an average of 10 days))
  • intraoperative blood loss(Duration of surgery and perioperative care (an average of 24 hours))
  • Vital signs of patients/blood pressure(perioperative (an average of 10 days))
  • Vital signs of patients/heart frequency(perioperative (an average of 10 days))
  • Vital signs of patients/stroke volume(perioperative (an average of 10 days))
  • Vital signs of patients/central venous oxygen saturation(perioperative (an average of 10 days))
  • Vital signs of patients/creatinine(perioperative (an average of 10 days))
  • ICU scores (TISS)(perioperative (an average of 10 days))
  • ICU scores (SOFA)(perioperative (an average of 10 days))
  • Vital signs of patients/Cardiac index(perioperative (an average of 10 days))
  • Vital signs of patients/intrathoracic blood volume index(perioperative (an average of 10 days))
  • Vital signs of patients/central venous pressure(perioperative (an average of 10 days))
  • ICU scores (SAPS)(perioperative (an average of 10 days))
  • Vital signs of patients/systemic vascular resistance index(perioperative (an average of 10 days))
  • Vital signs of patients/extra vascular lung water index(perioperative (an average of 10 days))
  • Incidence of organ failure or complications(perioperative (an average of 10 days))
  • Vital signs of patients/pulse pressure variation(perioperative (an average of 10 days))
  • Vital signs of patients/global enddiastolic volume index(perioperative (an average of 10 days))
  • Vital signs of patients/blood gases(perioperative (an average of 10 days))
  • Vital signs of patients/Ventilator settings(perioperative (an average of 10 days))
  • Vital signs of patients/diuresis(perioperative (an average of 10 days))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sascha Treskatsch

Prof. Dr. med./ Deputy head of department

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验